Xylina T. Gregg, M.D.
Medical Oncology Physician · Salt Lake City, UT
Xylina T. Gregg, M.D. is a medical oncology physician with a practice address in Salt Lake City, Utah, and NPI 1972554459, issued on May 12, 2006. Check the license (Utah 6011093-1205, as entered in NPPES) on the Utah Medical Licensing Board; the Medicare figures below come from public CMS files.
- Name
- Xylina T. Gregg
- Credential
- M.D.
- Primary taxonomy
- Medical Oncology Physician 207RX0202X
- License number
- 6011093-1205 UT
Self-reported in NPPES; status is on the state search - Practice location
- 3838 S 700 E, Salt Lake City, UT 84106
- Phone
- (801) 269-0231
- Enumerated
- May 12, 2006
- Record last updated
- Oct 10, 2016 (not updated in 10 years: call before relying on the address or phone)
- Fax
- (801) 269-0304
- Medicare enrollment
- Enrolled (PECOS I20051222000283); accepts Medicare assignment
- Medical or professional school
- Baylor College Of Medicine, 1991
- Entity
- Type 1 · individual
Also registered at 3838 S 700 E
A shared address usually means a shared clinic or building; it does not show who employs whom.
- John Ackerly, M.D.Anesthesiology Physician1841298346
- Vilija Avizonis, M.D.Radiation Oncology Physician1003865932
- Kristin Barber, APRNPsychiatric/Mental Health Nurse Practitioner1376773556
- Judy Bendoski-Parrish, A.P.R.N.Family Nurse Practitioner1083660500
- Arun Bidwai, M.D.Anesthesiology Physician1578561072
- Nitin Chandramouli, MDMedical Oncology Physician1801845730
Verify Xylina T. Gregg in five checks
- 1IdentityNPI record in CMS NPPESNPI lookupConfirmed in NPPES
- 2LicenseActive license and public ordersUtah Medical Licensing Board
Search for license 6011093-1205Check the board - 3Other statesLicenses and actions elsewhereDocInfo (FSMB)Not checked
- 4ExclusionsMedicare and Medicaid bansHHS-OIG exclusion listNot checked
- 5CertificationBoard certificationABMS AOA NCCPA AANPNot checked
21% more Medicare Part D claims than the average medical oncology physician in 2024
853 Medicare Part D claims for 189 beneficiaries, against an average of 703 among the 4,230 providers of this specialty who prescribed in Part D. Brand-name drugs were 30% of claims.
Most prescribed
- Anastrozole183 claims
- Tamoxifen Citrate100 claims
- Hydroxyurea40 claims
- Imbruvica36 claims
- Acyclovir28 claims
- Aranesp24 claims
Source: CMS Medicare Part D Prescribers by Provider and Drug, 2024 (data.cms.gov). Part D covers prescriptions for Medicare patients only; drugs with fewer than 11 claims are not published.
The practice group's MIPS final score for 2023 (Medicare payment program): 73.9 of 100
The Merit-based Incentive Payment System score is reported for the practice group, not for one clinician alone. Four categories are weighted into the final score; the average among 454,083 clinicians with a measured score was 83.5.
Source: CMS Quality Payment Program, MIPS performance year 2023, group reporting; category weights for 2023 (qpp.cms.gov).
Industry payments in 2024: $4,789.04
70 payments; by number, the most common kind was food and beverage; the largest payer was Cornerstone Specialty Network LLC. The 3,343 providers of this specialty with any payment received $11,773.47 on average. Payments are reported by manufacturers, not by the provider, and are not a sign of wrongdoing.
Source: CMS Open Payments, program year 2024 (openpaymentsdata.cms.gov); average among providers of this specialty with at least one payment.
Bills Medicare through one group practice
- Utah Cancer Specialists PCSalt Lake City, UT
Source: CMS Doctors and Clinicians National Downloadable File (the group practices a clinician bills Medicare through) (data.cms.gov).
Medical Oncology Physician providers in Utah
There are 46 medical oncology physician records in Utah.
Other medical oncology physician records in Utah
- Wallace Akerley, MDSalt Lake City, UT1346330966
- Khaled Alhamad, MDSalt Lake City, UT1659926228
- Lisa Arnold, DOMurray, UT1043674666
- Roma Bhatia, M.DSalt Lake City, UT1134582323
- Saundra Buys, MDSalt Lake City, UT1568547255
- Justin Call, M.D.West Jordan, UT1124172697
- Nitin Chandramouli, MDSalt Lake City, UT1801845730
- Gregory Chipman, M.D.American Fork, UT1457493967
- Sarah Colonna, MDSalt Lake City, UT1689859407
- Kathleen Cooney, MDSalt Lake City, UT1073699039
Common questions
What is Xylina T. Gregg, M.D.'s NPI number?
Xylina T. Gregg, M.D.'s National Provider Identifier (NPI) is 1972554459, issued on May 12, 2006. An NPI identifies a provider in billing; it is not a license.
Where is Xylina T. Gregg, M.D. located?
The NPPES record lists a practice address at 3838 S 700 E, Salt Lake City, UT, 84106. Phone: (801) 269-0231. Providers update this record themselves, so call before visiting.
How can I verify Xylina T. Gregg, M.D.'s license?
NPPES lists Utah license number 6011093-1205, as entered by the provider. Search the Utah Medical Licensing Board at https://secure.utah.gov/llv/search/index.html. The NPPES record confirms identity only; the state search shows license status, expiration and public orders.
How much does Xylina T. Gregg, M.D. prescribe under Medicare Part D?
In 2024, Xylina T. Gregg, M.D. had 853 Medicare Part D claims for 189 beneficiaries; the average among medical oncology physician prescribers was 703. Part D covers Medicare prescriptions only.
What is Xylina T. Gregg, M.D.'s MIPS final score?
The 2023 MIPS final score is 73.9 of 100, reported for the practice group. The average among 454,083 clinicians with a measured score was 83.5.
Source: CMS National Plan and Provider Enumeration System (NPPES), file of Aug 9, 2026 (NPPES files on CMS.gov); NUCC Health Care Provider Taxonomy. Medicare files from data.cms.gov. An NPI identifies who bills; it is not a license.
Figures on PlainDoctor are read from the federal files each page names (CMS NPPES, Medicare Part D, MIPS, Open Payments; the HHS-OIG exclusion list only as counts) and from Census population estimates, with the file date shown beside them. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of Aug 9, 2026.